The same study showed that VEGF-C (a VEGFR3 ligand) upregulated lymphangiogenesis, improved immune cell clearance, and decreased tissue inflammation, suggesting a therapeutic approach for alleviating adipose tissue inflammation in obesity. This evidence concerns the gene FLT4 and obesity due to melanocortin 4 receptor deficiency.